Renaissance Capital logo

Biopharmaceutical company NeurogesX files for IPO

February 7, 2007

NeurogesX, a biopharmaceutical company focused on developing on commercializing novel pain management therapies, filed for an IPO on Wednesday. Morgan Stanley is the lead manager on the deal. Terms and timing are yet to be announced.